|
Market Closed -
NYSE
01:30:00 17/09/2026 am IST
|
5-day change | 1st Jan Change | ||
| 2.680 USD | +0.75% |
|
+0.37% | +48.89% |
| Market Cap | 22Cr 19Cr 18Cr 16Cr 30Cr 2.07TCr 30Cr 211.14Cr 82Cr 1.05TCr 81Cr 79Cr 3.35TCr | P/E 2026 * |
11.2x | P/E 2027 * | 53.6x |
|---|---|---|---|---|---|
| Enterprise Value | 22Cr 19Cr 18Cr 16Cr 30Cr 2.07TCr 30Cr 211.14Cr 82Cr 1.05TCr 81Cr 79Cr 3.35TCr | EV / Sales 2026 * |
2.63x | EV / Sales 2027 * | 3.25x |
| Free-Float |
96.12% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| PLX | Delayed | |
CBOE
| PLX | Real-time | |
|
Tradegate
| PBDA | Real-time | |
|
Börse Stuttgart
| PBDA | Delayed | |
|
Deutsche Boerse AG
| PBDA | Delayed | |
|
Boerse Muenchen
| PBDA | Real-time |
Last Transcript: Protalix BioTherapeutics, Inc.
| 1 day | +0.75% | ||
| 1 week | +0.37% | ||
| Current month | +4.28% | ||
| 1 month | +20.72% | ||
| 3 months | +30.10% | ||
| 6 months | -6.62% | ||
| Current year | +48.89% |
| 1 week | 2.62 |  | 2.79 |
| 1 month | 2.28 | | 2.79 |
| Current year | 1.72 | | 3.19 |
| 1 year | 1.6 | | 3.19 |
| 3 years | 0.82 | | 3.19 |
| 5 years | 0.7 | | 3.55 |
| 10 years | 0.7 | | 15.15 |
| Manager | Title | Age | Since |
|---|---|---|---|
Dror Bashan
CEO | Chief Executive Officer | 59 | 30/06/2019 |
Gilad Mamlok
DFI | Director of Finance/CFO | 57 | 24/08/2025 |
Ori Kalid
CTO | Chief Tech/Sci/R&D Officer | - | 01/06/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Amos Bar Shalev
BRD | Director/Board Member | 73 | 01/07/2008 |
Aharon Schwartz
BRD | Director/Board Member | 83 | 01/11/2014 |
Dror Bashan
BRD | Director/Board Member | 59 | 30/06/2019 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 03/09/26 | Free | Director | 25,500 | 0.0316% | ||
| 03/09/26 | Free | Chairman | 25,500 | 0.0316% | ||
| 03/09/26 | Free | Chief Executive Officer | 4,80,000 | 0.5957% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.75% | +0.37% | +37.44% | +51.41% | 22Cr | |
| +0.15% | +1.21% | +48.79% | +97.65% | 1,01400Cr | |
| +0.03% | +0.07% | +51.47% | +65.55% | 64TCr | |
| -0.20% | +4.62% | +21.39% | +72.57% | 46TCr | |
| +0.53% | +4.26% | +40.29% | +38.70% | 35TCr | |
| +0.39% | +2.35% | +17.96% | +23.87% | 27TCr | |
| +0.17% | +4.17% | +6.96% | +10.93% | 25TCr | |
| +0.19% | -3.81% | +37.81% | +44.35% | 20TCr | |
| -1.20% | -5.64% | -24.09% | -59.10% | 19TCr | |
| +0.94% | +1.39% | +33.21% | +95.16% | 18TCr | |
| Average | +0.17% | +0.90% | +27.12% | +44.11% | 35.67TCr | |
| Weighted average by Cap. | +0.11% | +1.41% | +34.38% | +59.76% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 8.22Cr 7.12Cr 6.73Cr 6.11Cr 11Cr 788.16Cr 12Cr 80Cr 31Cr 399.76Cr 31Cr 30Cr 1.27TCr | 6.65Cr 5.76Cr 5.45Cr 4.94Cr 9.27Cr 637.76Cr 9.32Cr 65Cr 25Cr 323.48Cr 25Cr 24Cr 1.03TCr |
| Net income | 1.96Cr 1.7Cr 1.61Cr 1.46Cr 2.74Cr 188.33Cr 2.75Cr 19Cr 7.42Cr 96Cr 7.37Cr 7.21Cr 304.48Cr | 37.94L 32.88L 31.08L 28.21L 52.88L 36Cr 53.19L 3.71Cr 1.43Cr 18Cr 1.43Cr 1.39Cr 59Cr |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 16/26/16 | $2.680 | +0.75% | 10,59,291 |
| 15/26/15 | $2.660 | -3.97% | 8,12,742 |
| 14/26/14 | $2.770 | +4.92% | 9,52,160 |
| 11/26/11 | $2.640 | -3.30% | 6,46,807 |
| 10/26/10 | $2.730 | +2.25% | 7,82,524 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- PLX Stock
Select your edition
All financial news and data tailored to specific country editions
